Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Byotrol Plc | BYOT | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.10 | 00:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.10 |
| Industry Sector |
|---|
| CHEMICALS |
| Top Posts |
|---|
Posted at 25/9/2024 13:43 by sikhthetech Yet another of 1gw's shares crashes (AGAIN)...NTQ Whatever happened to the in-depth analysis, 1gw??? down 43% due to a placing. 1gw using the same line to ramp them as he did on Byot... Brokers, IP valuation... Isn't Finncap part of Cavendish now???? 1gw25 Sep '24 - 10:03 - 2264 of 2268 Cavendish have produced a note with some forecasts out to profitability in FY27 and a number for the IP valuation. Byot: 1gw30 Sep '20 - 20:02 - 6961 of 8034 <...> So on the product sales we seem to be running pretty well for the £12m revenue (which after all was just a run-rate calculation as I said), given 2H tends to be the bigger half anyway. finnCap are of course trying to be conservative about 2H, but if coronavirus cases continue to grow why wouldn't the sales continue at the £1m/month sort of level, especially if the supply chain is working better? |
Posted at 01/5/2024 18:59 by football BACK TO NEWSByotrol plc admitted to trading on Asset MatchOUR NEWSWEDNESDAY, MAY 01, 2024We are pleased to welcome Byotrol plc to the platform and announce its admission to the Asset Match Private Market.Byotrol plc (BYOT) is a specialist infection prevention and control company, operating globally in the Animal and Human Healthcare sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, moulds, mycobacteria and algae. Byotrol's products can be used stand-alone or as ingredients within existing products, where they can significantly improve their performance, within increasingly stringent regulatory environments.The Company intends run a quarterly auction schedule in the Ordinary Shares. Shares were admitted to trading at 0.11 pence per share (the last traded price on AIM).HTtps://assetma |
Posted at 25/4/2024 19:09 by sikhthetech cliffpeat"So despite what BYOT board says, it is possible (though expensive) to raised money on AIM." With Byot, the problem isn't the market, it's the BoD's decision making, or lack of it, especially during covid. The shares were around 10p but the actions were still flawed, as evidenced by the lack of sales, repeat sales. The company newsflow showed the BoD were failing to seize the opportunities presented to them. |
Posted at 25/4/2024 18:49 by cliffpeat @1gw post 12895.Yep - hands up - wrong company. The plc listed on AIM in April 2023 raising (gross) £6m (net c£4.7m) But OHT is another AIM loss making business. At 31 December 2023 the group accumulated losses were £30.8m after an annual loss of £3.4m. There had been top-line growth in sales but still a way to go to break-even and profit. So despite what BYOT board says, it is possible (though expensive) to raised money on AIM. Anyway - my derisory 300k of shares is now worth almost nothing - I haven't sold but don't expect to hear any more from BYOT Ltd other than LinkedIn reports of what they are doing for free :) |
Posted at 21/4/2024 18:20 by sikhthetech Brownson,#12861 Agree. It wasn't the company telling everyone that everything is going well. It was 1gw and his mates overplaying the potential, making up the potential and underplaying the risks. The company newsflow showed that sales were slowing during the pandemic. I highlighted it several times. Lack of sales, repeat sales: Any business is judged by repeat sales. Despite the biggest pandemic in 100yrs, Byot had lack of sales. I highlighted that as a red flag as well Re Tristel: Tristel made it clear what they thought about Byot, years ago. I highlighted that as well. More importantly, I also questioned why given 1gw and his mates portray themselves as well researched posters, do virtually all their stories turn out to be fiction, why virtually all their shares crash. I've also asked how many multiple ids does 1gw use and why? |
Posted at 04/4/2024 13:10 by kumbuka mudbath12 Jan '13 - 10:06 - 7 of 12704 0 0 0 The covering analyst at Finncap,Dr.Keith Redpath,suggests that Byotrol might lose £700k over the full year to Mar 31st 2013.This would indicate a loss of just £23k for the current six months. If correct,the losses for the past 3 six monthly trading periods would read:- March 2012= £1377k Sept 2012= £677k March 2013= £23k An impressive trend then,which if maintained, could see BYOT report profits of over £500k for the six months to Sept 2013;although Byotrol house brokers are forecasting a more modest 300k profit for the full year. Reading between the lines,BYOT are looking at a surge in orders.Why else would they be seeking to put in place a significant invoice discounting facility with their bankers. With an IDF in place,Finncap predict BYOT could turn cash flow neutral within the current trading period,possibly then precluding the need for a further large cash raising exercise After several disappointing years,Byotrol seems to be coming good at quite a pace,and imo this pace could quicken Finncap have in place an initial share price target of 15 pence. The share price chart currently looks strong and it could be that such a level is soon tested. A very interesting investment opportunity. |
Posted at 20/3/2024 12:41 by kumbuka BYOTmudbath 12 Jan '13 - 10:06 - 7 of 12570 0 0 0 The covering analyst at Finncap,Dr.Keith Redpath,suggests that Byotrol might lose £700k over the full year to Mar 31st 2013.This would indicate a loss of just £23k for the current six months. If correct,the losses for the past 3 six monthly trading periods would read:- March 2012= £1377k Sept 2012= £677k March 2013= £23k An impressive trend then,which if maintained, could see BYOT report profits of over £500k for the six months to Sept 2013;although Byotrol house brokers are forecasting a more modest 300k profit for the full year. Reading between the lines,BYOT are looking at a surge in orders.Why else would they be seeking to put in place a significant invoice discounting facility with their bankers. With an IDF in place,Finncap predict BYOT could turn cash flow neutral within the current trading period,possibly then precluding the need for a further large cash raising exercise After several disappointing years,Byotrol seems to be coming good at quite a pace,and imo this pace could quicken Finncap have in place an initial share price target of 15 pence. The share price chart currently looks strong and it could be that such a level is soon tested. A very interesting investment opportunity. |
Posted at 30/11/2023 13:16 by sikhthetech 1gw#12222 "They have called out disappointing sales in Human Healthcare in H1" I warned about low consumer sales over 3 years ago, when you were misleading readers about sales, Finncap being conservative etc I take it you're not looking for an excuse to sell. That'll be disgraceful behaviour wouldn't it? Try and be honest for once. I see you/your mates are ramping HVO, Polb, SLN, TRMR. Given you portray yourself as a well researched poster, why do the vast majority of your shares crash after you have ramped them? You make a dodgy 2nd hand car salesman sound honest. How many multiple ids do you have and why? sikhthetech - 04 Dec 2022 - 20:27:36 - 10513 of 12322 BYOTROL-CAN DELIVER AMAZING RESULTS - BYOT 1gw, "I think Amazon is a relatively new endeavour for byotrol." It's jam tomorrow. As you very well know during the biggest pandemic to hit the world in 100yrs, Byot had a £590k (yes k) increase in GLOBAL consumer sales. And that was because there was a world wide shortage so people had no alternative. As I said at the time, the pandemic was the golden opportunity presented on a plate but they missed it. Consumer sales a virtually non-existent and therefore jam tomorrow. Your jam tomorrow is endless and repeated every few months for years but never materialised. Btw how did Hycolin do on Amazon despite being originally listed last year??? You're very selective in your comments and have a selective memory depending on your agenda, which currently is ramping. H1 results possibly due this week. Best see what they say rather than baseless jam tomorrow fro (if going by last year) sikhthetech - 07 Jan 2021 - 14:57:21 - 7339 of 8923 1gw, Facts from their H1-2021 accounts published last month. Rest is jam tomorrow. £590k (yes k) increase in global consumer sales when there's the biggest pandemic to hit the globe is not impressive. So with the biggest pandemic to strike in a century they managed £997k (ex-royalty & licensing) of consumer sales! That includes Boots, Homeandcleaning, direct website sales, global sales. Consumer: "H1 revenues more than doubled to £1.01m from £0.41m, including a small amount of IP-based income, versus nil IP income in the comparable period. Gross profit (on products) increased to £0.43m from £0.17m. " "Elsewhere, sales across existing customers all increased in this segment, especially into Japan via our longstanding agents in pet and healthcare." 1gw - 16 Nov 2023 - 12:28:44 - 12222 of 12322 BYOTROL-CAN DELIVER AMAZING RESULTS They have called out disappointing sales in Human Healthcare in H1 |
Posted at 08/9/2023 11:56 by loafofbread At least we know where our supply of Brown seaweed will be coming from and our first partnership/developm06 July 2023 Byotrol Plc ("Byotrol" or the "Company") Patent Granted for Novel Anti-viral Seaweed Extract Byotrol Plc (AIM: BYOT), the specialist infection prevention and control company, is pleased to report the approval today of a UK patent following its discovery of unique anti-viral properties of certain enhanced extracts of commonly available brown seaweed. The award is a result of many years of research by Byotrol's technical team at its laboratories at Thornton Science Park, a University of Chester campus, and has been supported by the research scientists at the University of Liverpool led by Professor James Stewart, and by funding received from the Biotechnology and Biological Sciences Research Council (BBSRC) and Innovate UK. The grant of the patent application gives Byotrol validated, valuable and protected intellectual property, to support the development of commercial relationships. In the UK and Europe, seaweed extracts are not as yet approved as active materials for biocidal products, Byotrol's established area of expertise. So, we are now actively exploring alternative applications in very sizeable markets such as over-the-counter (OTC) products for the prophylactic treatment of viral conditions including colds, flu, coronaviruses and cold sores. Byotrol Plc's Chairman, Dr Trevor Francis, comments: "We are delighted to have secured the first patent for our seaweed-based anti-viral technologies. It is another good indication of the quality of our technical capability, and it will most certainly help us as we intensify the search for commercial partners. It also adds to our already significant level of intellectual property in antimicrobials. "This patent further confirms Byotrol's commitment to developing and commercializing natural and sustainable antimicrobial actives." |
Posted at 23/8/2023 06:03 by football Todays RNs WednesdayByotrol PLC Investor Presentation via Investor Meet Company 23/08/2023 7:00am RNS Non-Regulatory TIDMBYOT Byotrol PLC 23 August 2023 RNS Reach Byotrol plc ("Byotrol" or the "Company") Investor Presentation via Investor Meet Company Byotrol plc (AIM: BYOT), the specialist infection prevention and control company is pleased to announce that Vivan Pinto, CEO, David Traynor, Executive Director, and Chris Sedwell, CFO, will provide a live presentation relating to the Full Year Results via Investor Meet Company on 8th Sep 2023 at 11:00am BST. The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation. Investors can sign up to Investor Meet Company for free and add to meet BYOTROL PLC via: Investors who already follow BYOTROL PLC on the Investor Meet Company platform will automatically be invited. For further information, visit www.byotrolplc.com , follow on twitter @byotrol, or contact |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
